Ziva DRA brings together regulatory, clinical, market, business and project expertise to support healthcare and life-science companies navigating product registration, evidence generation, market entry, compliance and growth.
A medical device launch may require regulatory assessment, technical documentation, market research and local compliance. A pharmaceutical project may combine dossier, GMP, clinical and investment workstreams. Our team model is built around those intersections.
Ziva DRA's team structure is designed to reduce the fragmentation that often appears in regulated market-entry projects.
Team involvement is structured around the actual regulatory or business outcome required.
Relevant regulatory, clinical, market and business perspectives can be connected early.
Advice is shaped around the information, documentation and facts available to the project.
The objective is to translate analysis into clearer workstreams and next steps.
Replace the placeholder names, titles, biographies and images below with verified Ziva DRA team information before publishing.
Add the verified professional biography here, including relevant regulatory, healthcare, pharmaceutical or management experience.
Add verified experience covering product registration, technical documentation, regulatory assessment or regulated-market compliance.
Add verified experience related to medicine registration, dossier preparation, GMP, quality or pharmaceutical regulatory strategy.
Add verified expertise covering clinical research, evidence strategy, protocols, scientific writing or related research activities.
Add verified experience in market research, competitor analysis, healthcare intelligence, commercial strategy or market-entry research.
Add verified experience related to company formation, trade licensing, tax, VAT, investment or Bangladesh business-establishment support.
Projects can involve one specialist discipline or a coordinated team across several workstreams.
Support across registration, documentation, classification and regulatory planning.
Clinical development, evidence planning, protocols and scientific documentation.
Research and commercial intelligence supporting market-entry and investment decisions.
International strategy supporting multi-market regulatory and expansion planning.
Corporate and operational support behind regulated-market entry.
Coordination across disciplines where multiple workstreams affect the same business decision.
Rather than forcing complex projects into a single discipline, Ziva DRA can bring together the capabilities needed at each stage of the project.
The regulatory specialist may define the pathway, the clinical team may assess evidence, the market team may evaluate commercial viability and the business-compliance team may support the local operating structure.
Each workstream is aligned with the same business outcome.
Relevant expertise is assigned according to project need.
Teams consider how one workstream affects another.
Outputs are structured to support the next project decision.
When regulatory, clinical, commercial and business perspectives are connected, critical dependencies can become visible earlier.
Bring relevant expertise into one project structure.
Identify cross-functional issues before execution.
Reduce fragmentation across connected workstreams.
Translate specialist input into practical next steps.
Understand how Ziva DRA approaches complex regulatory and market-entry work.
Explore Why Ziva →Discuss a regulatory, market or business-compliance project with the team.
Contact Ziva DRA →The team profiles and stock images above are placeholders. Replace every name, job title, biography, expertise claim, photograph and professional credential with verified Ziva DRA team information. Do not publish placeholder profiles as if they represent actual employees or consultants.
Share your product, industry, current status and target outcome with Ziva DRA. We can identify which regulatory, clinical, market-intelligence or business-compliance capabilities should be brought into the project.